170 related articles for article (PubMed ID: 35982591)
1. Secretory Carcinoma of the Breast Mimicking Invasive Ductal Carcinoma: A Case Report.
Kovalenko I; Roy P; Soni B; Sangha L; Toom S
Am J Case Rep; 2022 Aug; 23():e936665. PubMed ID: 35982591
[TBL] [Abstract][Full Text] [Related]
2. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.
Makretsov N; He M; Hayes M; Chia S; Horsman DE; Sorensen PH; Huntsman DG
Genes Chromosomes Cancer; 2004 Jun; 40(2):152-7. PubMed ID: 15101049
[TBL] [Abstract][Full Text] [Related]
3. Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene Fusion.
Del Castillo M; Chibon F; Arnould L; Croce S; Ribeiro A; Perot G; Hostein I; Geha S; Bozon C; Garnier A; Lae M; Vincent-Salomon A; MacGrogan G
Am J Surg Pathol; 2015 Nov; 39(11):1458-67. PubMed ID: 26291510
[TBL] [Abstract][Full Text] [Related]
4. Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients.
Zhao YY; Ge HJ; Yang WT; Shao ZM; Hao S
Breast Cancer Res Treat; 2024 Feb; 203(3):543-551. PubMed ID: 37897648
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features and genomic profiles of a group of secretory breast carcinomas in which progressive cases have more complex genomic features.
Lei T; Yang Y; Shi Y; Deng X; Peng Y; Wang H; Chen T
Diagn Pathol; 2022 Dec; 17(1):101. PubMed ID: 36585729
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma.
Li L; Wu N; Li F; Li L; Wei L; Liu J
Cancer Biol Med; 2019 Feb; 16(1):139-146. PubMed ID: 31119054
[TBL] [Abstract][Full Text] [Related]
7. Rare breast cancer: 246 invasive secretory carcinomas from the National Cancer Data Base.
Jacob JD; Hodge C; Franko J; Pezzi CM; Goldman CD; Klimberg VS
J Surg Oncol; 2016 Jun; 113(7):721-5. PubMed ID: 27040042
[TBL] [Abstract][Full Text] [Related]
8. Genomic profile of a secretory breast cancer with an ETV6-NTRK3 duplication.
Lambros MB; Tan DS; Jones RL; Vatcheva R; Savage K; Tamber N; Fenwick K; Mackay A; Ashworth A; Reis-Filho JS
J Clin Pathol; 2009 Jul; 62(7):604-12. PubMed ID: 19561229
[TBL] [Abstract][Full Text] [Related]
9. Secretory carcinoma of the breast: a genetically defined carcinoma entity.
Diallo R; Tognon C; Knezevich SR; Sorensen P; Poremba C
Verh Dtsch Ges Pathol; 2003; 87():193-203. PubMed ID: 16888913
[TBL] [Abstract][Full Text] [Related]
10. Secretory breast carcinoma in an 8-year-old girl: A case report and literature review.
Garlick JW; Olson KA; Downs-Kelly E; Bucher BT; Matsen CB
Breast J; 2018 Nov; 24(6):1055-1061. PubMed ID: 30251458
[TBL] [Abstract][Full Text] [Related]
11. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
Curigliano G; Criscitiello C
J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
[TBL] [Abstract][Full Text] [Related]
12. Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry.
Diallo R; Schaefer KL; Bankfalvi A; Decker T; Ruhnke M; Wülfing P; Jackisch C; Luttges J; Sorensen PH; Singh M; Poremba C
Hum Pathol; 2003 Dec; 34(12):1299-305. PubMed ID: 14691916
[TBL] [Abstract][Full Text] [Related]
13. Secretory carcinoma of the breast, commonly exhibits the features of low grade, triple negative breast carcinoma- A Case report with updated review of literature.
Banerjee N; Banerjee D; Choudhary N
Autops Case Rep; 2021; 11():e2020227. PubMed ID: 34277491
[TBL] [Abstract][Full Text] [Related]
14. Clonal profiling of mixed lobular and ductal carcinoma revealed by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
Tajiri R; Inokuchi M; Sawada-Kitamura S; Kawashima H; Nakamura R; Oyama T; Dobashi Y; Ooi A
Pathol Int; 2014 May; 64(5):231-6. PubMed ID: 24888777
[TBL] [Abstract][Full Text] [Related]
15. A study on clinico-pathological assessment of response to neoadjuvant chemotherapy in breast carcinoma.
Mohapatra M; Sarma YS
J Cancer Res Ther; 2020; 16(6):1419-1425. PubMed ID: 33342807
[TBL] [Abstract][Full Text] [Related]
16. The management of ductal carcinoma in situ (DCIS). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
CMAJ; 1998 Feb; 158 Suppl 3():S27-34. PubMed ID: 9484276
[TBL] [Abstract][Full Text] [Related]
17. Male secretory breast cancer: case in a 6-year-old boy with a peculiar gene duplication and review of the literature.
Ghilli M; Mariniello MD; Scatena C; Dosa L; Traficante G; Tamburini A; Caporalini C; Buccoliero AM; Facchini F; Colizzi L; Quattrini Li A; Landucci E; Manca G; Naccarato AG; Caramella D; Favre C; Roncella M
Breast Cancer Res Treat; 2018 Aug; 170(3):445-454. PubMed ID: 29616377
[TBL] [Abstract][Full Text] [Related]
18. Advancement of secretory breast carcinoma: a narrative review.
Min N; Zhu J; Liu M; Li X
Ann Transl Med; 2022 Nov; 10(21):1178. PubMed ID: 36467350
[TBL] [Abstract][Full Text] [Related]
19. Secretory breast carcinoma in a 41-year-old man with long-term follow-up: a special report.
Li G; Zhong X; Yao J; Chen J; Wang M; Liu H; Yang S
Future Oncol; 2015; 11(12):1767-73. PubMed ID: 26075445
[TBL] [Abstract][Full Text] [Related]
20. Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature.
Angarita FA; Rodríguez JL; Meek E; Sánchez JO; Tawil M; Torregrosa L
World J Surg Oncol; 2013 Jun; 11():128. PubMed ID: 23734899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
